The Pursuit of Intravesical and Systemic Therapies in Non-muscle-invasive Bladder Cancer: Challenges and Opportunities

Eur Urol Oncol. 2023 Jun;6(3):321-322. doi: 10.1016/j.euo.2023.03.006. Epub 2023 Apr 10.

Authors

Fady Ghali¹, Jonathan L Wright², Petros Grivas³

Affiliations

¹ Department of Urology, University of Washington, Seattle, WA, USA.
² Department of Urology, University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA.
³ Fred Hutchinson Cancer Center, Seattle, WA, USA; Division of Oncology, Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: pgrivas@uw.edu.

PMID: 37045706
DOI: 10.1016/j.euo.2023.03.006

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antineoplastic Agents* / therapeutic use
Humans
Non-Muscle Invasive Bladder Neoplasms*
Urinary Bladder Neoplasms* / drug therapy

Substances

Antineoplastic Agents